Pharmaceutical giant Pfizer, and life sciences tools provider Thermo Fisher Scientific announced today they will collaborate to help expand local access to NGS-based lung cancer and breast cancer testing in more than 30 countries in Latin America, Africa, and the Middle East in areas where these tests and technologies have…

Genetic testing could determine which young breast cancer survivors are at highest risk of a second primary breast cancer (SPBC) and thus help others avoid unnecessary treatment, according to a new study. Their findings suggests young breast cancer survivors without a germline pathogenic variant have a low risk of developing…

Preliminary data from a survey of patients with breast cancer conducted in five European countries by Cancer Patients Europe’s (CPE) Cancer my Concern (myC) initiative found that four-in-five patients eligible for genomic testing are not told it is available to them. Further, despite the proven utility of such testing for…

A new study from researchers at the Mayo Clinic Cancer Center and collaborators from the CARRIERS consortium suggests that women over 65 with breast cancer could benefit from hereditary cancer genetic testing. These results, the researchers say, could affect further diagnostic testing, prevention, and treatment. The study was published in…

Testing positive for a high-risk breast cancer gene doesn’t always lead to the most appropriate care, a new study finds. Women who tested positive for such variants were more likely to receive bilateral mastectomy, which is in line with current guidelines.  But they were also less likely to receive radiotherapy…

Today Color Genomics unveiled the Benefits Program for Genetic Testing for Breast and Ovarian Cancer Risk, a first-of-its-kind initiative to offer this type of testing to an organization’s employee base. The initial partners include 18 organizations from the Bay Area and surrounding area, who are pledging to offer their employees…

Owkin and AstraZeneca have partnered on an AI-powered tool to pre-screen for germline BRCA (gBRCA) in breast cancer, directly from digitized pathology slides. This tool aims to significantly accelerate and expand access to gBRCA testing that many patients may not be considered for. The solution is currently in development and…

Researchers at the University College London (UCL) have developed a new handheld scanner that generates highly detailed 3D photoacoustic images in just seconds, an advancement that could provide for earlier diagnosis of cancer, cardiovascular disease, and arthritis. The study, published today in Nature Biomedical Engineering, details the technology at the…

Researchers from the Wellcome Sanger Institute and their collaborators investigated RAD51C and uncovered over 3,000 harmful genetic changes that could potentially disrupt its function and increase cancer risk in breast and ovarian cancer. The findings are published in the journal Cell and paves the way for better risk assessment and…

A 10-year study from researchers at the Yale School of Medicine has demonstrated that use of digital breast tomosynthesis (DBT) increases breast cancer detection rates and significantly reduces the rate of advanced cancer than does the standard screening method of two-dimensional digital mammography. Mammography has long been considered the gold…

A new study, published this week in the Annals of Internal Medicine, finds total expenditures for cancer screening in the U.S. topped $43 billion based on 2021 data. The research, led by Michael Halpern, MD, PhD, from the National Institutes of Health (NIH), used national health survey and resources data…

Earlier this year, Princess Kate Middleton announced that she had cancer. The world responded with shock, partly because she’s only 42. Her 75-year-old father-in-law, King Charles, was also diagnosed almost simultaneously. His announcement drew widespread sympathy as well, but nothing like the shock that greeted Kate’s news. “She is so…

A new study from the Mayo Clinic finds that current screening protocols fail to catch a significant number of individuals with genetic mutations linked to hereditary breast and ovarian cancer syndrome (HBOC) and Lynch syndrome, which increase the risk of developing certain cancers. Their findings, published in JCO Precision Oncology,…

Many breast cancer survivors eligible for genetic counseling and testing are not receiving it according to a new study from the University of Michigan (U-M) Health Rogel Cancer Center. This is increasingly important as cancer treatment and follow up are getting more complex as more new drugs are being introduced.…

Researchers have known for some time that about seven percent of people diagnosed with low-risk prostate cancer following a biopsy actually have the deadly form of the disease. Recently, some experts have called for the lowest grade of prostate cancer—biopsy Gleason Grade Group (GGG) 1—to be reclassified as “benign.” A…